Clinical Trial

Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Current guidelines suggest postoperative spine Stereotactic Body Radiation Therapy (SBRT) should be delivered within 2-4 weeks after surgery. This approach is rife with logistical complications that create delays and barriers for patients accessing care. An alternative approach delivers postoperative spine SBRT soon after surgery, starting within a single hospital stay. This study will investigate the effects of short-term postoperative spine SBRT on wound complications in a safety lead-in, then will transition to a phase 2 trial investigating local tumor control.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-05-31 -> 2027-10-31 2026-05-15
minor Completion pushed: 2027-05-31 -> 2027-10-31 2026-05-15
Trial Details
NCT Number NCT07346170
Lead Sponsor University of California, San Francisco
Conditions Spine Metastasis, Stereotactic Body Radiation Therapy (SBRT)
Enrollment 50 participants
Start Date 2026-07-15
Primary Completion 2027-10-31 (estimated)
Study Completion 2027-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-14